Skip to content

Differential effect of single saturated fat feeding interventional trial in on blood triglycerides in healthy individuals.

Differential effects of short, medium and long chain saturated fatty acids on cardiovascular disease risk factors in healthy adults,

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12617000903381
Enrollment
15
Registered
2017-06-20
Start date
2017-06-24
Completion date
2017-09-13
Last updated
2017-07-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

In both scientific and public domain, dietary saturated fatty acids (SFAs) are linked with adverse health effects. However, epidemiological and interventional studies have produced contradictory results. Although negative views about SFAs have prevailed, there is increasing evidence to suggest that SFAs are not as harmful as they appear to be and may not be the prime cause of elevated blood lipid levels. Some studies have shown that SFAs induce beneficial effects on blood lipid profiles and that not all SFAs have the same effect on cardiovascular health. SFAs are classified as short (SCFA), medium (MCFA) and long (LCFA) chain fatty acids. SCFA range between 2 to 4 carbons atoms and are found in milk and dairy products. MCFA contain 6 to 12 carbons atoms and are found in coconut oil, palm kernel oil and citrus seeds. LCFA are 14 or more carbons long and are found in animal products like lard, tallow and suet. The digestion, absorbtion and metabolism of fatty acid depends on their chain length. SCFA and MCFA are easily broken down and undergo rapid beta-oxidation for energy production. However LCFA are not easily digested and are deposited in the peripheral tissues. Thus it is convincing to suggest that consumption of SCFA and MCFA, because of their unique structural, absorption and metabolic characteristics can lower blood fat levels and result in less accumulation of fat in the adipose tissues. Evidence from pre-clinical studies have demonstrated that short and medium chain fatty acids do not contribute to obesity, improves blood lipid profiles and other cardiovascular risk factors. If the same is true for humans, naturally occurring SCFA and MCFA intake might help prevent cardiovascular and other chronic diseases. Thus, we hypothesize that short chain saturated fats (butter), medium chain saturated fats (coconut oil) may not be hyperlipidemic as long chain saturated fats (lard).

Interventions

Short chain fatty acid (butter 40 gram ), medium chain fats (coconut 40 gram ) and long chain fats (lard 40 gram ). Test food will be delivered in the form of biscuits. Biscuits will be made using wholemeal flour, cornflour, icing sugar and 40 gram lard or coconut or butter. Different flavours like orange, lemon and vanilla will be used to prepare biscuits. Participants should consume 6 biscuits (40gram fats) within 15 minutes in front of study staff. Participants will stay in the research area

Short chain fatty acid (butter 40 gram ), medium chain fats (coconut 40 gram ) and long chain fats (lard 40 gram ). Test food will be delivered in the form of biscuits. Biscuits will be made using wholemeal flour, cornflour, icing sugar and 40 gram lard or coconut or butter. Different flavours like orange, lemon and vanilla will be used to prepare biscuits. Participants should consume 6 biscuits (40gram fats) within 15 minutes in front of study staff. Participants will stay in the research area for at least 6-7 hours. All participants will participate for consuming 3 test food with a week wash out period.

Sponsors

University of Newcastle
Lead SponsorUniversity

Study design

Allocation
Randomised controlled trial
Intervention model
Crossover
Primary purpose
Prevention
Masking
Open (masking not used)

Eligibility

Sex/Gender
All
Age
18 Years to 64 Years
Healthy volunteers
Yes

Inclusion criteria

Aged 18-65 years, healthy males or females with Body mass index (BMI) between 18 and 25Kg/m2

Exclusion criteria

• Have BMI >25 Kg/m2; • Are pregnant or breast feeding; • Take any lipid lowering drugs (eg. statins or supplements (e.g. fish oil), or non-steroidal anti-inflammatory drugs (NSAIDs), or anti-hypertensive drugs, or vasodilators, or antioxidants vitamins. • Are dieting or have any eating disorders; • Have sensitivity or intolerance to any of the food products or ingredients used in the study; • Have history of congestive heart failure, stroke, myocardial infarction, coronary artery bypass graft, or atherosclerotic CVD; or pulmonary disease • Have history of diabetes, hypertension, triglycerides higher than 3.0 mmol/L; total cholesterol higher than 5.5 mmol/L; • Have history of gastrointestinal disorder, gall bladder disease, or liver disease; • Taking any dietary supplements that influence blood lipid profile or inflammation; • Smoke; • Vegetarian or vegans

Outcome results

None listed

Source: ANZCTR · Data processed: Mar 4, 2026